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New studies suggest that stem cells of embryonic, neural, and hematopoietic origin are heterogeneous, with
cells moving between two or more metastable states. These cell states show a bias in their differentiation
potential and correlate with specific patterns of transcription factor expression and chromatin modifications.How stem cells balance their self-renewal capacity and their abil-
ity to differentiate are central questions in stem cell research.
Here we review recent findings supporting the notion that het-
erogeneity is a hallmark of both embryonic and adult stem cells.
This heterogeneity might have evolved as a mechanism that
enables stem cells to respond to differentiation-inducing signals
while retaining their self-renewal potential.
Regulation of Embryonic Stem Cell Self-Renewal
and Differentiation
The first differentiation event during mammalian development is
the segregation of trophectodermand inner cellmass (ICM) at the
late morula state. The ICM goes on to form the primitive endo-
derm and the epiblast, which during gastrulation gives rise to the
three primordial germ layers and ultimately to all cell types of the
embryo proper. Embryonic stem cells (ESCs) are immortal cell
lines derived from the ICM of mouse and human blastocysts.
Similarly, pluripotent epiblast stem cells (EpiSCs) and embryonic
germ cells (EGCs) are cell lines derived from epiblast stage em-
bryos and primordial germ cells, respectively (Yu and Thomson,
2008). The twomost defining features of ESCs are their unlimited
in vitro self-renewal capacity combined with their ability to differ-
entiate into all somatic cell types. A number of transcription
factors, most prominently Oct4, Nanog, Klf4, and Sox2, have
been identified as positive regulators that induce and maintain
self-renewal and the undifferentiated state of ESCs (Jaenisch
and Young, 2008). The power and importance of these genetic
regulators was dramatically demonstrated by their induction of
pluripotency in fibroblasts (Takahashi and Yamanaka, 2006).
Several studies reported that transcription factors associated
with pluripotency are expressed in a heterogeneous fashion in
ESC cultures. For example, approximately 80%of ESCs express
Nanog, while 10%–20% do not (Chambers et al., 2007; Singh
et al., 2007). In addition, Gata6, a transcription factor governing
primitive endoderm formation, is predominantly expressed in
Nanogneg cells (Singh et al., 2007). ESCs also display heteroge-
neity with regard to expression of the transcription factor Rex1
(Toyooka et al., 2008). This heterogeneity is not due to the coex-
istence of independent cell populations, since culturing of iso-
lated marker positive and negative fractions restored cells with
the original expression pattern, implying that the two populations
can convert into each other. What is the biological significance of
this heterogeneity? It turns out that the different Nanog sub-
populations exhibit distinct differentiation biases: Nanogpos480 Cell Stem Cell 3, November 6, 2008 ª2008 Elsevier Inc.ESCs generate undifferentiated cell colonies at high frequencies,
while Nanogneg cells show a higher propensity for differentiation
(Chambers et al., 2007). ESCs are therefore able to switch
between one state biased toward self-renewal and another
biased toward differentiation. Interestingly, cellular heterogene-
ity can also be seen in vivo. That is, in the ICM, Gata6 and Nanog
are expressed in an apparently random but mutually exclusive
‘‘salt-and-pepper’’ fashion (Chazaud et al., 2006). The expres-
sion of these factors is probably subject to extracellular signal-
ing, since abrogation of Grb2, a member of the MAP kinase
pathway, induces expression of Nanog in all cells of the ICM at
the expense of Gata6 expression and primitive endoderm forma-
tion. Similarly, treatment of ESCs with an antagonist of the MAP
kinase pathway leads to Nanog repression and induces differen-
tiation (Toyooka et al., 2008). These and other experiments
suggested that self-renewal represents the ESC ground state.
In support of this idea, murine ESCs can be maintained in a
self-renewing state in the absence of leukemia inhibitory factor
(LIF) or other extrinsic signals when the MAP kinase pathway is
blocked (Ying et al., 2008). However, LIF signaling might never-
theless be necessary for the initial establishment of pluripotency,
as was suggested by recent work with facultative pluripotent cell
lines established from the mouse ICM (Chou et al., 2008). In con-
clusion, these data suggest that ESCs, and possibly also other
pluripotent cells, can move between different metastable cell
states that are accompanied by fluctuations in transcription
factor expression. These states differ in their responsiveness
to differentiation-inducing extracellular stimuli.
A recent paper by Surani and colleagues (Hayashi et al., 2008)
sheds new light on themolecularmechanisms underlying hetero-
geneity of gene expression in ESCs. The authors noted thatStella
is expressed in 20%–30% of ESCs, using a cell line with a GFP
reporter gene driven from promoter elements of the stella gene.
Stella, also known as PGC7 or Dppa3, has been implicated in
the maintenance of gene-specific DNA methylation in the early
embryo (Nakamura et al., 2007). Phenotypically, Stella-GFPpos
ESCs resemble ICM cells, since they express Nanog and Rex1
at high levels. By contrast, Stella-GFPneg ESCs are more
epiblast-like, as they express Fgf5 and Gbx2 at levels intermedi-
ate between Stella-GFPpos ESCs and epiblast-derived stem
cells. When Stella-GFPpos and Stella-GFPneg ESC fractions
were isolated and placed in separate cultures, the original distri-
bution of marker gene expression was restored. In spite of
their interchangeability, the two populations exhibited distinct
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more readily into cells expressing somatic as well as trophecto-
dermal markers than did Stella-GFPpos cells, which were more
prone to give rise to embryoid bodies. The relatively low abun-
dance of Stella-GFPpos ESCs (30%) compared to Nanogpos
ESCs (80%) suggests that theNanog-positive subset is hetero-
geneous or, alternatively, that Stella fluctuations have a longer off
phase.
How are the Stella-positive and negative ESC subpopulations
established? Insight into this question came from the analysis of
histone modifications at the endogenous stella locus. Thus,
H3K4me3 and H3K9ac, histone modifications associated with
gene activation, were more prevalent in Stella-GFPpos than in
Stella-GFPneg ESCs and lowest in EpiSCs. In addition, the stella
promoter was largely unmethylated in Stella-GFPpos and Stella-
GFPneg ESCs, indicating an active state, whereas it was heavily
methylated in EpiSCs, indicating an inactive state. Treatment of
ESCs with the histone deacetylase inhibitor Trichostatin A
increased the proportion of Stella-GFPpos cells, while the DNA
methylation inhibitor 5-azacytidine had no effect. These obser-
vations suggest that histone modifications can transiently stabi-
lize the oscillatory expression of transcription factors involved in
self-renewal and differentiation of ESCs. Subsequently, when
ESCs commit to become EpiSCs, DNA methylation irreversibly
silences inappropriate gene expression, thus demarcating a
developmental boundary between ESCs and EpiSCs. Figure 1
shows a summary of these findings and their interpretation.
Heterogeneity of Adult Stem Cells
Can subpopulations with distinct biological properties also be
observed in adult stem cells, or are they limited to embryonic
stem cells? Adult stem cells are present in numerous tissues,
such as bone marrow, gut, and skin, where they serve to replace
cells lost to injury, attrition, or natural turnover. They are rare,
mostly quiescent cells that are contained within specialized
niches in the body. These properties, together with the limited
self-renewal potential of most adult stem cells in culture, compli-
cate their study at the molecular level. Nevertheless, a growing
body of evidence indicates that at least some adult stem cell
types are heterogenous. Tracking the expression of the G pro-
tein-coupled receptor Lgr5 identified an intestinal stem cell
(ISC) population located at the base of the crypt (Barker et al.,
2007). More recently, Capecchi and colleagues identified an-
other ISC population (Sangiorgi and Capecchi, 2008) using the
polycomb repressor complex protein Bmi1 as an indicator. The
Bmi1pos ISC is located at a higher position within the crypt,
thus occupying a different niche. Both Lgr5pos and Bmi1pos
ISCs are capable of generating all epithelial cell types of the small
intestine, but the latter commit to differentiation more slowly, in-
dicating that they aremore quiescent. This observation suggests
that Bmi1pos ISCs are precursors of Lgr5pos ISCs. Nevertheless,
it is still possible that the two ISCs represent two lineages with
distinct developmental origins, or that they can convert into
each other.
Several lines of evidence indicate that hematopoietic stem
cells (HSCs), the best-studied adult stem cell type, also consist
of distinct subpopulations. HSCs are functionally defined by their
multilineage, long-term reconstitution potential when trans-
planted into irradiated mice and constitute approximately 1 in10,000 nucleated cells in the bone marrow. Various protocols,
most of them using combinations of antibodies against cell-
surface markers, permit enrichment of HSCs to a high degree
of purity. In a systematic study to resolve the question whether
individual HSCs differ in their self-renewal and differentiation po-
tential, single HSCs were transplanted into mice analyzed for the
presence of donor-derived cells at different times in both primary
as well as in secondary and tertiary recipients (Dykstra et al.,
2007). Of about 100 mice with long-term reconstitution exam-
ined, four distinct patterns of reconstitution were observed,
which were used to retrospectively define the transplanted cells.
Two HSC types with long-term reconstitution potential were
identified: a type HSCs, which produced a substantially higher
proportion of myeloid cells (macrophages and granulocytes)
compared to lymphoid progeny (B and T cells); and b type
HSCs, which showed a much more balanced distribution of
lineage output. When bone marrow cells from primary recipients
cells were transplanted into secondary and even tertiary hosts,
these patterns remained reproducible, suggesting that the two
types of HSCs are stabilized by epigenetic mechanisms. Nota-
bly, however, approximately half of the HSCs that generated
an a cell type repopulation pattern in primary recipients switched
to a b cell repopulation pattern when serially transplanted, while
the reverse was not observed. Together, these observations
suggest that HSCs fall into two (or more) subpopulations that ex-
hibit distinct self-renewal and differentiation biases. The fact that
conversions between these subpopulations appear to be unidi-
rectional, at least under the somewhat artificial conditions of
transplantation, raises the possibility that the mechanisms that
generate heterogeneity in embryonic stem cells and HSCs differ.
To unravel the molecular mechanisms involved in the establish-
ment of the two HSC subsets it will now be necessary to identify
Figure 1. Heterogeneity of Embryonic Stem Cells
ESCs consist of various cell subsets that express different levels of specific
markers (such as Stella and the transcription factors Nanog and GATA-6)
and that continuously convert into each other. These subsets grossly recapit-
ulate different stages between the ICM and epiblast-like cells. The oscillations
between the subsets (indicated by the broken arrow) involve changes in
histone modifications. In contrast, the developmental transition to EpiSCs is
irreversible and involves methylation of ESC-specific promoters, such as
Stella. Cells expressing Stella and Nanog are biased toward self-renewal,
where cells at the other end of the spectrum are biased toward differentiation
(Hayashi et al., 2008).Cell Stem Cell 3, November 6, 2008 ª2008 Elsevier Inc. 481
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HSCs.
Using antibody based cell separation techniques, HSC sub-
sets with distinct phenotypic and functional properties were
recently described (Haug et al., 2008). These authors separated
HSCs based on N-cadherin expression. A first subset termed
‘‘reserved’’ HSCs expresses N-cadherin at intermediate levels
and has poor repopulation potential and low cell-cycle entry
rate; a second subset, termed ‘‘primed’’ HSCs is N-cadherin
low, has robust repopulation potential, and expresses genes
that might prime them for mobilization. Reserve HSCs acquire
both phenotypic and functional characteristics of primed HSCs
upon overnight culture. N-cadherin is an adhesion molecule
thought to help anchoring HSCs into the osteogenic niche,
although the expression of N-cadherin by HSCs and their
requirement for it have recently been called into question (Kiel
et al., 2007). Nonetheless, the findings fromHaug and colleagues
suggest that the bone marrow contains two partially intercon-
vertible HSC populations, at least in the context of in vitro
culture. Whether these subsets correspond to the two types of
HSCs identified in the study of Eaves and colleagues (Dykstra
et al., 2007) remains unclear.
Oscillatory Gene Expression in Adult Progenitor
and Stem Cells
Whether biological ‘‘noise,’’ such as the stochastic fluctuations
of transcriptional regulators, contributes to cell lineage or fate
decisions has been intensively debated for some time. As early
as 15 years ago, it was shown that cytokine withdrawal induces
multilineage differentiation in a hematopoietic progenitor cell line
in which Bcl2 was overexpressed to prevent apoptosis (Fairbairn
et al., 1993). This finding is consistent with the idea that hemato-
poietic cells possess an intrinsic mechanism that generates
a spectrum of progeny with different differentiation biases, re-
sulting in commitment either spontaneously or as a consequence
of extracellular cues. In support of this concept is the observa-
tion that HSCs express a variety of lineage-restricted genes at
low levels (Miyamoto et al., 2002). The conflicting coexpression
of various lineage-associated programs within individual cells
becomes resolved once progenitors commit and lineage-spe-
cific genes are selectively upregulated (Miyamoto et al., 2002).
A recent study by Huang and colleagues (Chang et al., 2008)
directly demonstrated that stochastic-oscillatory expression of
lineage-associated genes can drive cell-fate commitment (see
also Figure 2). Using the myeloid-erythroid precursor EML cell
line as a model, they showed that Sca-1, a cell surface marker
of HSCs and some early progenitors, is expressed in a broad,
bell-shaped pattern. Culturing either Sca-1pos and Sca-1neg
cell fractions regenerated the original antigen distribution after
12 population doublings with no obvious differences in timing
between the two subfractions. Mathematical modeling sug-
gested that the observed slow fluctuation of Sca-1 expression
resulted from a process involving stochastic transitions between
multiple metastable states. Most strikingly, the cells at the ex-
tremes of the spectrum differed in their differentiation potential:
Sca-1pos cells were strongly biased toward myeloid differentia-
tion, Sca-1neg cells toward erythroid differentiation. This corre-
lated with the expression of the transcription factors PU.1 and
GATA-1, which are known to play antagonistic roles in the spec-482 Cell Stem Cell 3, November 6, 2008 ª2008 Elsevier Inc.ification of myeloid and erythroid fates (Graf, 2002). The data
thus indicate that multipotent progenitors express lineage-
instructive transcription factors in a mutually exclusive fashion
and in an oscillatory manner, continuously generating cells that
exhibit distinct differentiation biases. A theoretical model of line-
age commitment controlled by antagonistic cross-interaction
between PU.1 and GATA-1 was recently proposed by Huang
and Enver (Huang et al., 2007). Of note, primary multipotent
blood progenitor cells in the bone marrow can also be subdi-
vided into a myeloid-primed fraction and an erythroid-primed
fraction based on the expression of PU.1 and GATA-1 (Arinobu
et al., 2007). This raises the possibility that different states of
multipotent hematopoietic progenitors also oscillate in vivo.
Direct evidence that oscillations of gene expression presage
commitment in normal multipotent precursors comes from the
study of neural progenitors (Shimojo et al., 2008). The cell sur-
face receptor/transcription factor Notch has long been known
to be a key determinant of neural cell fate. In neural progenitors,
activation of Notch signaling represses neural fate through ligand
binding, and progenitors expressing elevated levels of ligand
prevent neighboring cells from becoming neurons. The effects
of Notch are mediated by upregulation of the helix-loop-helix
transcription factor (HLH) Hes1. Performing real-time live imag-
ing of cultured neural precursors and in vivo, Kageyama and
colleagues observed that Hes1 expression oscillates with
a wavelength of 2–3 hr. Overexpression of Hes1 in neural precur-
sors induced the downregulation of the neural genes Delta-like1
and Neurogenin2. Importantly, Delta-like1 and Neurogenin2
also oscillate, with peaks corresponding to the valleys of Hes1
expression, suggesting that Hes1 oscillations drive Delta-like1
and Neurogenin2 oscillations. Experiments using the Notch in-
hibitor gamma secretase indicates that Notch signaling is also
required for the induction of Hes1 oscillations under physiologi-
cal conditions. In conclusion, antagonistic oscillations of neural
and nonneural genes preceding cell commitment appear to be
necessary for commitment while maintaining a stem cell state.
What sets Hes1 oscillations in motion? It is unlikely that the
Figure 2. Heterogeneity of Hematopoietic Progenitor Cells
The scheme summarizes data obtained with the EML cell line, which can be
induced toward myeloid and erythroid differentiation using different cytokines
(Chang et al., 2008). EML cells exhibit a broad spectrum of Sca-1 expression,
and cells with different levels of Sca-1 restore the original spectrum when cul-
tured (arrow). Sca-1high cells exhibit a high ratio of PU.1 versus GATA-1 ex-
pression and are biased toward myeloid differentiation; Sca-1neg cells show
a high ratio of GATA-1 versus PU.1 expression and are biased toward erythroid
differentiation.
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because their wavelength is considerably shorter than 1 day.
Instead, Shimojo et al. suggest that the oscillations are regulated
by Jak/Stat signaling (Shimojo et al., 2008). However, even if
substantiated, the chicken and egg question remains. Perhaps
the oscillations result from an amplification of noisy expression
of specific regulatory factors and are modulated by positive
and negative feedback loops, as has been shown for genes in
yeast (reviewed by Arias and Hayward, 2006).
In conclusion, both embryonic and adult stem cells display
a surprising degree of heterogeneity caused by the oscillatory
expression of synergistically and antagonistically acting tran-
scription factors and stabilized by epigenetic modifications.
These fluctuations may have evolved to allow stem cells to
self-renew while also offering ‘‘windows of opportunity’’ to
respond to environmental signals that can trigger specific differ-
entiation.What generates stochastic fluctuations of transcription
factors in the first place and how the crosstalk between stem
cells and the niche translates into changes in transcriptional
networks and chromatin modifications remain hot questions in
stem cell research.
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